Background Evidence regarding the association between sarcopenia (skeletal muscle
depletion) and outcomes in patients with lung cancer varies across studies. We aimed to …

Metabolism encompasses the biochemical processes that allow healthy cells to keep
energy, redox balance and building blocks required for cell development, survival, and …

Objectives Low skeletal muscle mass (SMM) or sarcopenia is emerging as an adverse
prognostic factor for chemotherapy dose-limiting toxicity (CLDT) and survival in cancer …

Background The association between body composition (eg sarcopenia or visceral obesity)
and treatment outcomes, such as survival, using single‐slice computed tomography (CT) …

Introduction The primary objective of this study was to determine the prognostic significance
of computed tomography (CT)-determined sarcopenia in small-cell lung cancer (SCLC) …

Background Sarcopenia is an important prognostic factor of lung cancer. The serum
creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine× cystatin C …

Sarcopenia is a very common, but frequently overlooked and undertreated geriatric
syndrome comprising pronounced muscle mass and strength/performance loss. Estimated …

Objectives Sarcopenia is characterized by progressive and generalized loss of skeletal
muscle mass and strength. We aimed to investigate sarcopenia in patients with stage I non …

Background Skeletal muscle depletion (sarcopenia) is closely associated with limited
physical ability and high mortality. This study evaluated the prognostic significance of …

Body composition measurement using diagnostic computed tomography (CT) scans has
emerged as a method to assess sarcopenia (low muscle mass) in oncology patients …